Latest Breaking News On - Therapeutics company profile - Page 8 : vimarsana.com

Research Analysts Set Expectations for CRISPR Therapeutics AG s Q2 2024 Earnings (NASDAQ:CRSP)

Research Analysts Set Expectations for CRISPR Therapeutics AG s Q2 2024 Earnings (NASDAQ:CRSP)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Jamesr kasingerSamarth kulkarniWells fargo companyRiggs asset managment coSecurities exchange commissionOrion capital managementRoyal bankTherapeutics company profileItau unibanco holdingFree reportBrookline capital managementCapital managementGet free reportWells fargoAsset managmentSpire wealth management

Shield Therapeutics (LON:STX) Trading Down 8 8%

Shield Therapeutics (LON:STX) Trading Down 8 8%
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United kingdomAccrufer feraccruTherapeutics company profileShield therapeuticsGet free reportShield therapeutics daily

Plus Therapeutics (PSTV) Set to Announce Quarterly Earnings on Wednesday

Plus Therapeutics (PSTV) Set to Announce Quarterly Earnings on Wednesday
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

March hedrickTherapeutics incTherapeutics company profilePlus therapeuticsGet free reportPlus therapeutics daily

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 11 3%

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 11 3%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Raju prasadSamarth kulkarniNeedham companyBourgeon capital managementTherapeutics company profileSecurities exchange commissionRoyal bankPrincipal securities incRiggs asset managment coWells fargo companyHeadlands technologiesBlue trust incGet free reportChardan capitalWells fargoExchange commission

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $65 00

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $65 00
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Samarth kulkarniJamesr kasingerRobertw bairdCantor fitzgeraldBlue trust incRiggs asset managment coWells fargo companyBourgeon capital managementSecurities exchange commissionNeedham companyTherapeutics company profileTradewinds capital managementHeadlands technologiesFree reportWells fargoTrading down